From joint anatomy to clinical outcomes in osteoarthritis and cartilage repair: Summary of the fifth annual osteoarthritis imaging workshop

Osteoarthritis and Cartilage

Volumn 19, Issue 11, 2011, Pages 1263-1269

  Hunter, D J ^a   Eckstein, F ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Imaging workshop; Osteoarthritis

Indexed keywords

BIOLOGICAL MARKER;

DIAGNOSTIC IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; VALIDATION PROCESS;

BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CONGRESSES AS TOPIC; HUMANS; JOINTS; MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS;

EID: 80053645156     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.08.005     Document Type: Review

References (25)

1. Eckstein F., Cicuttini F., Raynauld J.P., Waterton J.C., Peterfy C. Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment. Osteoarthritis Cartilage 2006, (14 Suppl 1):46-75.
2. Roemer F.W., Eckstein F., Guermazi A. Magnetic resonance imaging-based semiquantitative and quantitative assessment in osteoarthritis. Rheum Dis Clin North Am 2009, 35:521-555.
3. Ossendorf C., Steinwachs M.R., Kreuz P.C., Osterhoff G., Lahm A., Ducommun P.P., et al. Autologous chondrocyte implantation (ACI) for the treatment of large and complex cartilage lesions of the knee. Sports Med Arthrosc Rehabil Ther Technol 2011, 3:11.
4. Trattnig S., Domayer S., Welsch G.W., Mosher T., Eckstein F. MR imaging of cartilage and its repair in the knee - a review. Eur Radiol 2009, 19:1582-1594.
5. Marlovits S., Singer P., Zeller P., Mandl I., Haller J., Trattnig S. Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol 2006, 57:16-23.
6. Domayer S.E., Welsch G.H., Dorotka R., Mamisch T.C., Marlovits S., Szomolanyi P., et al. MRI monitoring of cartilage repair in the knee: a review. Semin Musculoskelet Radiol 2008, 12:302-317.
7. Peterfy C.G., Schneider E., Nevitt M. The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis Cartilage 2008, 16:1433-1441. [Review] [40 refs].
8. Reichmann W.M., Maillefert J.F., Hunter D.J., Katz J.N., Conaghan P.G., Losina E. Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. Osteoarthritis Cartilage 2011, 19:550-556.
9. Lester G. Clinical research in OA - the NIH Osteoarthritis Initiative. J Musculoskelet Neuronal Interact 2008, 8:313-314.
10. Hawker G.A. Experiencing painful osteoarthritis: what have we learned from listening?. Curr Opin Rheumatol 2009, 21:507-512.
11. Gossec L., Paternotte S., Maillefert J.F., Combescure C., Conaghan P.G., Davis A.M., et al. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage 2011, 19:147-154.
12. Food and Drug Administration Guidance for Industry. Clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA) 17-3-2009. Ref Type: Electronic Citation. http://www.fda.gov/Cber/gdlns/osteo.htm.
13. Mazzuca S.A., Brandt K.D. Is knee radiography useful for studying the efficacy of a disease-modifying osteoarthritis drug in humans?. Rheum Dis Clin North Am 2003, 29:819-830. [Review] [22 refs].
14. Mazzuca S.A., Brandt K.D., Buckwalter K.A., Lequesne M. Pitfalls in the accurate measurement of joint space narrowing in semiflexed, anteroposterior radiographic imaging of the knee. Arthritis Rheum 2004, 50:2508-2515.
15. Hunter D.J., Losina E., Guermazi A., Burstein D., Lassere M.N., Kraus V. A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials. Curr Drug Targets 2010, 11:536-545.
16. Matthews G.L., Hunter D.J. Emerging drugs for osteoarthritis. Expert Opin Emerg Drugs 2011, 16(3):479-491.
17. Abramson S.B., Berenbaum F., Hochberg M.C., Moskowitz R.W. Introduction to OARSI FDA initiative OAC special edition. Osteoarthritis Cartilage 2011, 19:475-477.
18. Neogi T., Felson D., Niu J., Nevitt M., Lewis C.E., Aliabadi P., et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 2009, 339:b2844.
19. Hunter D.J., Zhang W., Conaghan P.G., Hirko K., Menashe L., Li L., et al. Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthritis Cartilage 2011, 19(5):557-588.
20. Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 2001, 32:1598-1606.
21. Altar C.A. The biomarkers consortium: on the critical path of drug discovery. Clin Pharmacol Ther 2008, 83:361-364.
22. Revkin J.H., Shear C.L., Pouleur H.G., Ryder S.W., Orloff D.G. Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future. Pharmacol Rev 2007, 59:40-53. [Review] [87 refs].
23. FDA Critical path initiative 17-3-2009. Ref Type: Electronic Citation. http://www.fda.gov/oc/initiatives/criticalpath/.
24. Zerhouni E.A., Sanders C.A., von Eschenbach A.C. The biomarkers consortium: public and private sectors working in partnership to improve the public health. Oncologist 2007, 12:250-252.
25. Kraus V.B., Nevitt M., Sandell L.J. Summary of the OA biomarkers workshop 2009 - biochemical biomarkers: biology, validation, and clinical studies. Osteoarthritis Cartilage 2010, 18:742-745.